Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
CBIO — Crescent Biopharma, Inc.
NASDAQ
FULL STOCK PAGE →

Q1 2024 Earnings Call Summary

MAY 6, 2024
REVENUE
$0 -100.0%
EPS
-$16.66 -18.2%
FREE CASH FLOW
-$10.5M -38.1%

No summary has been written for this call yet.